Shanghai Jiaotong University

Other

Shanghai Institute of Endocrine and Metabolic Diseases

Sph Sine Pharmaceutical Laboratories Co., Ltd

Bgi Shenzhen

Perfect Company

Shanghai Institute for Endocrine and Metabolic Diseases

Guang Ning

Weiqing Wang

Jie Hong

Jiqiu Wang

Ruixin Liu

Xu Zhang

Jun Shi

Qiang Feng

Yuan Gao

Liping Zhao

Menghui Zhang

Xiaoying Li

Xiaojun Zhang

Yifei Zhang

Xiaoyan Pang

Peijun Yin

Linghua Wang

Shasha Wang

Hongjing Yu

Bin Wen

Ningyun Sun

Yufeng Zhao

Shouyue Sun

Xiaokai Wang

Xiaoqiang Xu

Yanyun Gu

Provided are anstrain and use thereof in preventing and treating metabolic diseases. This strain is namedSSYD-3 and the accession number thereof is CGMCC No. 14764. This strain is more ideal than the existingstrain ATCC BAA835 in respect of fermentation performance, storage stability, acid and bile resistance, and the effect on treating metabolic diseases.

Strain for preventing and treating metabolic diseases and use thereof

An infusion pump is disclosed comprising control unit, container, actuation unit and detection unit. The container can store medicinal liquid for treating hypogonadotropic hypogonadism. The control unit can receive external control signal comprising infusion interval, concentration of medicinal liquid and dose of medicament for treating hypogonadotropic hypogonadism at each infusion. The control unit is configured to activate actuation unit based on infusion interval to cause medicinal liquid to flow out of container. The detection unit can detect output of medicinal liquid from container and feed it back to control unit. The control unit is configured to activate actuation unit based on dose at each infusion, concentration of medicinal liquid and fed-back output of medicinal liquid. According to the invention, sustained, automatic infusions of the medicament for treating hypogonadotropic hypogonadism are allowed without patient intervention. As a result, intelligent infusion of medicament is achieved in an easy and efficient manner.

Infusion pump

Provided are uses ofin preparation of a medicament. The medicament is for use in treatment or prevention of obesity and obesity-related diseases. Also provided are a pharmaceutical composition, a medicament, a food product, and an animal feed that comprise, uses thereof in treatment or prevention of obesity and obesity-related diseases, and a method for treatment or prevention of obesity and obesity-related diseases.

[object Object]

A method and a composition for improving gut micro biota structure, selectively increase a first gut microbiota population while simultaneously decrease a second gut micro biota population in a subject. The first gut micro biota population includes a short-chain fatty acid (SCFA)-producing bacterium and the second gut microbiota population includes an endotoxin-producing bacterium.

Methods and compositions for improving gut microbiota population

Growing community of inventors

Shanghai, China

Guang Ning